ArticleAbdominal radiology (New York)2025
A case of plasmacytoid urothelial carcinoma with characteristic radiological findings.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The "perfect storm" in bladder oncology: a case of diverticular carcinoma with plasmacytoid features and its clinical ramifications.BMC urology · 2026Article
- Multiparametric MRI Features of Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.Korean journal of radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmacytoid urothelial carcinoma (PUC) is a rare and an aggressive subtype of invasive urothelial carcinoma, often diagnosed at advanced stages with poor prognosis. We report a case of PUC with characteristic radiological findings. A male patient in his 70s presented with nocturnal urinary incontinence; cystoscopy findings suggested cancer. Magnetic resonance imaging (MRI) revealed a 6-mm-sized protruding lesion of the bladder with early contrast enhancement and diffusion restriction, indicative of bladder cancer. Additionally, a diffuse bladder wall thickening, abnormal signal intensity, and contrast enhancement were observed around the bladder. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography showed no significant FDG uptake in the lesion. The possibility of peritoneal dissemination of gastrointestinal malignancy was considered; however, no obvious primary lesions were identified. PUC was suggested as a differential diagnosis, prompting random bladder biopsies during resection of a protruding lesion in the bladder. Immunohistochemical staining confirmed PUC, with positivity for CD138, CK7, and GATA3 and negativity for CDX-2 and E-cadherin. Following treatment with gemcitabine and cisplatin, the lesion size decreased. Diagnosis of PUC can be difficult because the lesion is not easily detected by cystoscopy, misdiagnosed as peritoneal dissemination of gastrointestinal cancer on CT or MRI, or histopathologically similar to plasmacytoma or malignant lymphoma. PUC may present with pelvic peritoneal spread of the tumor as thick sheets extending along the fascial planes, which may be a characteristic imaging finding. Radiologists must be aware of these typical imaging findings to ensure accurate diagnosis of PUC.
Indexed as
Identifiers
40214695What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.